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Introduction: In patients with COPD, severe physical inactivity (SPI, which is defined as total 
daily energy expenditure/resting energy expenditure; physical activity level [PAL] ratio, ,1.4) 
is associated with increased morbidity and mortality. Pulmonary rehabilitation (PR) increases 
physical capacity in COPD, but the impact on SPI is unknown. In this study, we aimed at elu-
cidating the prevalence of SPI in COPD patients attending standard PR, the impact of PR on 
SPI prevalence, and the relationship between SPI and time spent in moderate physical activity 
thus whether American College of Sports Medicine (ACSM) recommendations are clinically 
useful in excluding SPI in COPD.
Methods: This is a prospective non-interventional pilot study on patients with COPD completing 
PR, consenting to wear an accelerometer (Sensewear© Armband) for a week before and after 
completing PR to assess changes in energy expenditure, time spent in physical activity, and 
number of daily steps. Low level of daily physical activity was not an inclusion criterion.
Results: In total, 57 patients completed the study and 31 (54%) had SPI at baseline. In patients 
with SPI, baseline median FEV
1
 was 48 (range, 28–86) % of predicted and GOLD B, n=11 
(35%)/GOLD D, n=20 (65%). Surprisingly, 31 of SPI patients (97%) spent $150 minutes/week 
in moderate physical activity. After rehabilitation, 24 (78%) did not change activity level and 
were persistently SPI. We observed no differences at baseline between patient responding (n=7) 
vs not responding (n=24) to PR. Responders increased number of daily steps and time spent in 
lighter but not moderate physical activity during rehabilitation.
Conclusion: In this pilot study, SPI was prevalent, and PR had limited impact. Contraintui-
tively, most patients with SPI complied with general recommendations of weekly hours spent 
in moderate physical activity. Our study highlights that increasing time spent in light activity 
rather than improving time spent in moderate activity is important in COPD patients with 
chronic dyspnea.
Keywords: COPD, pulmonary rehabilitation, severe physical inactivity, Sensewear©
Introduction
COPD is associated with reduced levels of daily physical activity.1 The chronic airflow 
limitation results in exercise-limiting dyspnea and fatigue, and in particular, COPD 
patients are at risk for severe physical inactivity (SPI), which is defined as a total daily 
energy expenditure/resting energy expenditure ratio ,1.4.2–4 SPI is prevalent in the 
majority of COPD patients in GOLD group D5 and is highly related to both morbidity 
and mortality.6–8 However, SPI assessment requires measurement of resting energy 
expenditure by indirect calorimetry or an accelerometer (eg, SenseWear© Armband; 
BodyMedia, Pittsburgh, PA, USA) because no equation for calculated resting energy 
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expenditure has shown acceptable accuracy in COPD.9 
According to the American College of Sports Medicine 
(ACSM), healthy subjects are recommended to engage in 
moderate physical activity for 30 minutes a day – at least 
5 days a week – to reduce the risk of chronic diseases and 
disabilities.10 The same recommendations are applicable for 
older adults according to WHO.11 In COPD, it is not known 
whether complying with the ACSM goal precludes SPI.
Pulmonary rehabilitation (PR) is a validated intervention 
in COPD, and exercise is the cornerstone of the program.12 
Even though high intensity and duration of physical activity 
are negatively correlated to morbidity and mortality in 
COPD,2,5,6,13–15 it is not known whether the standard ACSM 
recommendation is a relevant success criterion for PR in 
COPD.6,7,16–19 Recent research has suggested that lighter 
activities are more efficient in avoiding inactivity including 
SPI than heavier physical activities.3,4,15,20,21
In the present study, we aimed at elucidating the preva-
lence of SPI in COPD patients attending standard PR, the 
impact of PR on the prevalence of SPI, and the relationship 
between SPI and time spent in moderate physical activity, 
thus it is unknown if the ASCM recommendations is clini-
cally useful in excluding SPI in COPD.
Methods
Design
This prospective, observational cohort study was designed 
as a pilot study and conducted in 2013–2014 in PR centers 
at Naestved Hospital and in the communities of Naestved, 
Faxe, and Vordingborg centers (Region Zealand, Denmark). 
Patients were enrolled on the first day of the rehabilitation 
program (Visit 1) and had a follow-up visit in the last week 
of the rehabilitation course (Visit 2).
Inclusion criteria
Inclusion criteria were physician-diagnosed COPD confirmed 
by spirometry (GOLD classes B–D),12 referral for PR, ability 
to give informed consent, no other life-threatening illnesses, 
no history of asthma, and no acute exacerbation within the 
last 4 weeks prior to inclusion.22
Written and oral informed consent was obtained. This 
study was approved by the Danish National Ethical Committee 
and complied with the Declaration of Helsinki. The study is 
registered with ClinicalTrials.gov (number 34431).
study procedures
The rehabilitation program consisted of exercise training, 
education in management of disease and pharmacology, 
nutrition, and help with smoking cessation. The duration 
of the program ranged from 7 to 12 weeks, 2 hours twice 
a week according to the guidelines from the Danish Health 
Authority.23 The exercise training consisted of 1 hour of 
supervised training twice a week with an equal distribution 
between endurance and resistance training.23 Spirometry 
(MicroLoop© spirometer; Becton, Dickinson and Company, 
Franklin Lakes, NJ, USA) measurement was performed 
at both visits according to the guidelines of the American 
Thoracic Society (ATS) and the European Respiratory 
Society (ERS).24 Patient-reported outcome measures were 
obtained at both visits. Background data were obtained at 
Visit 1: gender, weight, height, and exacerbations (acute 
exacerbation in COPD [AECOPD]) comorbidities and 
medication.
Primary and secondary outcomes
Primary outcome
The primary outcome of this study was the prevalence of 
SPI before and after PR.
secondary outcomes
The secondary outcome of this study was minutes spent 
in light respective moderate physical activity, number of 
patients spending $150 minutes/week in light ($2 Meta-
bolic Equivalent of Task [MET]) respective moderate ($3 
MET) physical activity, number of daily steps, and patient-
reported outcome measures (COPD assessment test [CAT] 
and mMRC) before and after PR.
Physical activity assessment
Subjects were instructed to wear an activity monitor 
(SenseWear Armband) continuously for 7 days after each 
study visit. The use of SenseWear in patients with COPD 
has previously been validated.29,30 According to the manu-
facturer’s recommendation, the activity monitor is worn on 
the back of the upper right arm at the level of the triceps. 
This monitor assesses acceleration in two planes by using 
a bi-axial accelerometer which measures and stores skin 
temperature, near body temperature, heat flux and galvanic 
skin resistance. Activity is estimated in MET, a measure of 
energy expenditure (1 MET=1 kcal/kg/h). Output from the 
SenseWear includes the following:
•	 Total energy expenditure (TEE): number of calories burnt 
every day.
•	 Resting metabolic rate (RMR): the rate at which the body 
burns energy when it is at complete rest.
•	 Physical activity level (PAL): TEE divided by the RMR.
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•	 Minutes spent at light ($2 MET) and moderate ($3 
MET) physical activity.
•	 Daily number of steps.
Data from patients wearing the monitor 2 days 
and 90% of daily use were included.25
Patient-reported outcome measures
CAT consisted of a self-reported, well-validated 5-point 
Likert scale, eight-item questionnaire with four respiratory 
items and four general health items (score range, 0–40).26 
mMRC scale consisted of a self-reported, well-validated, 
5-point Likert scale, one-item questionnaire (score range, 
0–4). A score $2 is considered “severe dyspnea” and is an 
inclusion criterion for PR in Denmark.12,18
statistical analyses
Statistical analyses were performed using STATA 14.1. 
Missing data were omitted from analyses.
Continuous data are presented as a median (range) and 
categorical data as incidence (%). Differences were assessed 
using the chi-squared test or Wilcoxon signed-rank test. 
Statistical significance was set at P,0.05.
Results
Patients
Between January 15, 2013, and February 10, 2014, 163 patients 
were consecutively screened, and 67 patients were included 
(Figure 1). Totally, 57 patients completed the trial (community-
based rehabilitation: n=43, 75%; hospital-based rehabilitation: 
n=14, 25%) and were included in the analysis (female: 53%; 
age, 68 years [range, 50–80 years]). Baseline median FEV
1
 was 
50 (range, 22–96) % of predicted, and patients were divided 
between GOLD class B (n=28) respective D (n=29). Median 
body mass index (BMI) was 27 kg/m2 (range, 17–51 kg/m2), 
and median self-reported number of moderate to severe 
AECOPD in preceding 12 months was 1 (0–7; Table 1). 
Patients completing the study and patients dropping out did 
not differ significantly in baseline characteristics. Eight of the 
patients (14%) had missing SenseWear data at either baseline or 
follow-up. Table 2 shows that 74% complied with the ASCM’s 
recommendation for physical activity at baseline and that PR 
increased time spent in light but not moderate physical activity. 
Nine patients (16%) used a walker, and they did not differ sig-
nificantly regarding daily steps or minutes/week spent in $3 
MET as opposed to patients not using walking aids. We reg-
istered the following comorbidities: 1) ischemic heart disease, 
n=3 (5%); 2) heart failure, n=12 (21%); 3) osteoporosis, n=5 
(9%); 4) arthritis or joint pain, n=32 (56%); 5) anxiety, n=18 
(32%); 6) depression, n=9 (16%); 7) stroke or other neurologic 
disease, n=5 (9%); and 8) diabetes, n=4 (7%).
Patients with sPI at baseline
Totally, 31 (54%) patients had SPI at baseline, yet 96% 
of patients with baseline SPI spent $150 minutes/week 
Figure 1 Flowchart of patients included in the study.
Abbreviation: aeCOPD, acute exacerbation in COPD; sPI, severe physical inactivity.
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in moderate physical activity ($3 MET), thus complying 
with ASCM recommendation for the general population 
(Table 2). Only seven patients (22%) responded to PR by 
increasing PAL to $1.4 (“responders”; Table 2). Responders 
significantly improved number of daily steps and time spent 
in lighter but not moderate physical activity compared to 
patients with persistent SPI. Analyzing differences between 
responders and patients with persistent SPI revealed no 
significant baseline differences (Table 3).
Discussion
This pilot study showed that SPI is prevalent in patients 
referred for PR and that rehabilitation improved objec-
tively measured physical activity in a minority of these 
patients. To our knowledge, this is the first study to address 
these issues.
It is well established that self-reported level of physical 
activity is poorly associated with objectively measured 
physical activity.27 Surprisingly, we found that 96% of 
patients with SPI spent $150 minutes/week in objectively 
measured moderate physical activity. Thus, the general 
recommendations for physical activity by ACSM10 seem not 
to be clinically meaningful in COPD patients with chronic 
dyspnea (mMRC, $2). Our data support that increasing 
lighter rather than moderate or hard physical activity is more 
efficient in reducing sedentary lifestyle.3,4,16,20,21 However, the 
paradoxical finding of sedentary lifestyle (SPI) and sufficient 
amounts of moderate physical activity might have other 
explanations. As SPI is defined as a low ratio between total 
daily energy expenditure and resting energy expenditure, 
SPI might be a result of low total daily energy expenditure 
and/or increased resting energy expenditure. Several studies 
have found that moderate to severe COPD is associated with 
increased resting energy expenditure, lower fat-free body 
mass, and increased protein turnover.4,5,28 In addition, more 
profound structural and metabolic changes in peripheral and 
respiratory muscles seen in COPD patients result in increased 
energy expenditure (kcal/kg/h=MET) at lower levels of 
exercise.29 This is even more pronounced with low BMI, as 
energy expenditure is weight dependent; however, Kao et al28 
found that low fat-free mass but not low BMI was associated 
with increased energy expenditure. We found no differences 
in baseline BMI in responders vs patients with persistent 
SPI (Table 2), but did not include measurements of fat-free 
mass. We found no differences in resting energy expenditure 
between responders and patients with persistent SPI, but the 
statistical power was low due to the limited sample size; thus, 
we cannot rule out that COPD patients with SPI benefiting 
from PR is a distinct subgroup.
The PAL and time spent in moderate physical activity 
are two different ways to measure physical activity, and 
both are important predictors of morbidity and mortality.6–8,10 
Although the impact of PR on quality of life (QoL), exer-
cise capacity, and dyspnea is well established, less evi-
dence exists on the impact on time spent in moderate daily 
physical activity, although some studies have focused on 
daily steps and walking speed.22,30–37
Table 1 group characteristics (n=57)
Visit 1
age (years), median (range) 68 (50–80)
Female gender, n (%) 30 (53)
BMI, median (range) 27 (17–51)
FeV1 (% predicted), median (range) 50 (22–96)
gOlD, n (%)
a 0 (0)
B 28 (49)
C 0 (0)
D 29 (51)
Community/hospital, n (%) 43 (75)/14 (25)
CaT, median (range) 17 (4–32)
mMrC, median (range) 2 (1–4)
aeCOPD in the recent year, median (range) 1 (0–7)
Abbreviations: aeCOPD, acute exacerbation in COPD; BMI, body mass index; 
CaT, COPD assessment Test.
Table 2 Impact of pulmonary rehabilitation on time spent in physical activity and number of patients being active for $150 minutes/
week measured using activity monitor (senseWear©) during 1 week
All participants (n=57)  SPI at baseline (n=31)
Baseline Follow-up Baseline Follow-up
hours/week at $3.0 MeT (moderate physical activity), median (range) 6.0 (0–59) 7.7 (0.1–32) 4.4 (0.2–21) 4.8 (0.1–14)
Patients with $3.0 MeT (moderate physical activity) in $150 minutes/week, n (%) 39 (74) 42 (79) 21 (69) 22 (76)
hours/week at $2.0 MeT (light physical activity), median (range) 18.8 (0.8–61) 21.5 (1.9–59)a 9.9 (0.8–39) 16.8 (1.9–31)
Patients with $2.0 MeT (light physical activity) in $150 minutes/week, n (%) 50 (94) 52 (98) 31 (97) 28 (97)
Note: aP,0.05, intragroup difference between time points.
Abbreviations: MeT, Metabolic equivalent of Task; sPI, severe physical inactivity.
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Limitations
There are several limitations in this study, which needs con-
sideration. First, the present study is a pilot study and thus 
vastly underpowered to draw solid conclusion on statistically 
insignificant findings. However, this observational study 
included COPD patients admitted daily for PR and was not 
preselected according to self-reported or measured levels of 
physical activity. Second, PR was delivered at four sites with 
different duration despite involving mandatory elements of 
training and education twice a week according to the Danish 
guidelines.23 Our data sample was too small to adjust for this 
heterogeneity. Yet, the recommended duration of PR varies 
among guidelines (4–12 weeks American Association of 
Cardiovascular and PR; $8 weeks ATS/ERS; not specified 
by ASCM), whereas these guidelines agree on sessions at 
least three times weekly.38 Thus, we might have observed 
a smaller impact of rehabilitation by following the Danish 
guidelines. It will be interesting to ascertain SPI prevalence 
as well as impact of rehabilitation in larger centers with more 
prevalent sessions.
Third, the accelerometer used (SenseWear) has – despite 
being well validated in COPD39 – several limitations. It is 
worn on the upper right arm and is not usable in water. Thus, 
measurements of energy expenditure during swimming or 
activities with fixed arms (eg, cycling, walking aids) are 
absent or underestimated. In our cohort, a minority used a 
walker. Furthermore, to ensure representative activity data, 
we excluded data if SenseWear was worn for ,48 hours or 
if on-body time was ,90%. In addition to the challenge of 
recollecting physical activity, Pitta et al40 reported adherence 
difficulties on using an accelerometer in 19% of COPD sub-
jects including body placement and technical issues, such as 
battery problems. In our study, the missing SenseWear data 
were 14% both due to exclusion criteria as mentioned above 
and complete lack of obtained data. Little is known about 
the day-to-day variations in objectively measured physical 
activity in moderate to severe COPD patients, but it is consid-
erable in healthy adults.41 It has been documented that PALs 
increase during the week wearing an accelerometer, probably 
due to the novelty-induced increased awareness of healthy 
living.41,42 Fourth, we did not adjust for comorbidities such as 
osteoporosis, low back pain, diabetes, poor nutrition, cogni-
tive dysfunction, heart disease, rheumatoid diseases, anxiety, 
or depression, which are all independently associated with 
decreased physical activity.38,40,43–46 Even though comor-
bidities are present in 70% of COPD patients and known to 
interfere with the outcome of PR, an improvement is still 
seen.47,48 However, the impact of exercise training provided 
during rehabilitation is not COPD specific, and all patients 
volunteered to participate in the rehabilitation program and 
the study. This selection probably selected the patients most 
eager to improve their levels of physical activity.
Table 3 subgroup analyses of patients with sPI at baseline (n=31): differences at baseline and follow-up between patients remaining 
severely inactive (sPI) and patients not being severely inactive (non-sPI) at follow-up (responders)
Persistent SPI (n=24) Responders (n=7)
Baseline Follow-up Baseline Follow-up
Physical activity level (Tee divided by rMr),  
median (range)
1.3 (1.2–1.3) 1.3 (1.1–1.3)a 1.3 (1.1–1.3)b 1.4 (1.4–1.5)a,b
resting energy expenditure (J/day) 6,552 (4,464–9,768) 6,969 (4,344–8,784) 6,432 (4,872–9,768) 7,032 (4,728–10,920)
steps, median (range) 1,758 (226–5,501) 1,683 (180–5,065)a 3,149 (112–4,755) 4,015 (1,598–5,564)a
Minutes/week at $3 MeT, median (range) 264 (12–1,098) 276 (6–810) 348 (48–1,284) 546 (138–1,704)
no of patients with $3 MeT in 150 minutes/week,  
n (%)
15 (60) 18 (75) 5 (71) 6 (86)
Minutes/week in $2 MeT, median (range) 552 (48–2,160) 960 (114–1,860)a 1,164 (252–2,340) 1,608 (1,200–2,520)a
no of patients with $2 MeT in 150 minutes/week,  
n (%)
22 (92) 23 (96) 7 (100) 7 (100)
CaT, median (range) 17 (10–32) 16 (7–29) 17 (11–28) 19 (11–34)
mMrC, median (range) 2 (1–4) 2 (0–4) 2 (1–4) 2 (1–4)
BMI, median (range) 27.9 (18.4–42.9) 27.0 (16.6–27.8)
FeV1 (% predicted), median (range) 48 (28–73) 54 (26–96)
COPD class B, n (%) 9 (38) 2 (29)
Notes: aIntergroup difference, P,0.05. bIntragroup difference, P,0.05. gray box, only baseline data available.
Abbreviations: BMI, body mass index; CaT, COPD assessment Test; MeT, Metabolic equivalent of Task; rMr, resting metabolic rate; sPI, severe physical inactivity; Tee, 
total energy expenditure.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
6.
87
.1
74
 o
n 
20
-N
ov
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2018:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3364
Thyregod et al
Conclusion
Our present pilot study suggests that objectively measured 
SPI is common in patients referred for PR, which only 
improves daily physical activity in a minority of subjects 
despite wearing an accelerometer in a clinical trial. SPI at 
baseline was not precluded by being moderately physically 
active for $150 minutes/week. As SPI is significantly asso-
ciated with morbidity and mortality, future studies should 
address SPI-focused intervention strategies and elucidate 
factors associated with failure to improve physical activity 
in COPD patients receiving PR.
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